Is PKBOW or NOBL a better dividend investment in 2026?

PKBOW currently yields 20202.02% with a 5% 5-year dividend growth rate. NOBL yields 2.17% with 5% growth. The better choice depends on your goal: PKBOW offers higher current income.

What is the dividend yield difference between PKBOW and NOBL?

PKBOW has a forward dividend yield of 20202.02% ($2.00/share annually). NOBL yields 2.17% ($2.27/share annually). The yield gap is 20199.85 percentage points.

Home › Compare › PKBOW vs NOBL

PKBOW vs NOBL: Dividend Comparison 2026

PKBOW yields 20202.02% · NOBL yields 2.17%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PKBOW wins by $57988137149625106432.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PKBOW

● Live price

20202.02%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$57988137149625106432.00M

Annual income

$57,428,928,743,751,610,000,000,000.00

Full PKBOW calculator →

NOBL

● Live price

2.17%

Share price

$104.67

Annual div

$2.27

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.9K

Annual income

$249.78

Full NOBL calculator →

Portfolio growth — PKBOW vs NOBL

📍 PKBOW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PKBOW	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PKBOW + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PKBOW pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PKBOW

Annual income on $10K today (after 15% tax)

$1,717,171.72/yr

After 10yr DRIP, annual income (after tax)

$48,814,589,432,188,870,000,000,000.00/yr

NOBL

Annual income on $10K today (after 15% tax)

$184.52/yr

After 10yr DRIP, annual income (after tax)

$212.31/yr

At 15% tax rate, PKBOW beats the other by $48,814,589,432,188,870,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PKBOW + NOBL for your $10,000?

PKBOW: 50%NOBL: 50%

100% NOBL50/50100% PKBOW

Portfolio after 10yr

$28994068574812553216.00M

Annual income

$28,714,464,371,875,805,000,000,000.00/yr

Blended yield

99.04%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PKBOW buys

NOBL buys

No recent congressional trades found for PKBOW or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPKBOWNOBL

Forward yield	20202.02% ✓	2.17%
Annual dividend / share	$2.00	$2.27 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$57988137149625106432.00M ✓	$22.9K
Annual income after 10y	$57,428,928,743,751,610,000,000,000.00 ✓	$249.78
Total dividends collected	$57951242634511319040.00M ✓	$2.3K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: PKBOW vs NOBL ($10,000, DRIP)

Year	PKBOW Portfolio	PKBOW Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$2,030,902	$2,020,202.02	$10,917	$217.08	+$2.02M → PKBOW
2	$385,615,342	$383,442,277.01	$11,903	$221.48	+$385.60M → PKBOW
3	$68,455,310,249	$68,042,701,832.74	$12,962	$225.68	+$68455.30M → PKBOW
4	$11,362,120,801,776	$11,288,873,619,809.51	$14,099	$229.68	+$11362120.79M → PKBOW
5	$1,763,290,309,334,738	$1,751,132,840,076,837.00	$15,319	$233.49	+$1763290309.32M → PKBOW
6	$255,866,846,080,109,380	$253,980,125,449,121,180.00	$16,628	$237.10	+$255866846080.09M → PKBOW
7	$34,717,188,276,404,167,000	$34,443,410,751,098,450,000.00	$18,033	$240.53	+$34717188276404.15M → PKBOW
8	$4,404,848,409,251,598,600,000	$4,367,701,017,795,846,700,000.00	$19,539	$243.78	+$4404848409251598.50M → PKBOW
9	$522,624,678,386,435,660,000,000	$517,911,490,588,536,450,000,000.00	$21,154	$246.86	+$522624678386435648.00M → PKBOW
10	$57,988,137,149,625,104,000,000,000	$57,428,928,743,751,610,000,000,000.00	$22,884	$249.78	+$57988137149625106432.00M → PKBOW

PKBOW vs NOBL: Complete Analysis 2026

PKBOW — Stock

Peak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics addressing unmet needs in the areas of oncology and inflammation. The company's proprietary toxin, PH-1 or Thailanstatin, a spliceosome modulator is being used to generate its first pipeline of novel ADC product candidates to address unmet needs in cancer patients. Its lead product candidate, PHP-303, is a small molecule awaiting Phase II dose clinical study in the orphan disease Alpha1 anti-trypsin deficiency (AATD). The company is based in Palo Alto, California.

Full PKBOW Calculator →

NOBL — ETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →

📬

Get this PKBOW vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PKBOW vs SCHD PKBOW vs JEPI PKBOW vs O PKBOW vs KO PKBOW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.